As seems to be the case for many other conditions, including cerebral small vessel disease [37], NFL in CAA is likely to find utility as a marker of the intensity of neurodegeneration and so a useful measure of prognosis rather than diagnosis, particularly as it can be measured in the serum; further work is needed to investigate this. The gene discussed is NEFL; the disease is cerebral small vessel disease.